John Prosper Mack - 24 Jun 2025 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Reporting relationship: Director
Issuer ticker: OBIO
Reported as of: 24 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Jun 2025, 17:19:17 UTC
Prior SEC filing: 08 Aug 2024
Next SEC filing: 08 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Andrew Taylor, Attorney-in-Fact

Key filing fact

John Prosper Mack filed Form 4 for Orchestra BioMed Holdings, Inc. (OBIO) on 26 Jun 2025.

Key facts

This page summarizes John Prosper Mack's Form 4 filing for Orchestra BioMed Holdings, Inc. (OBIO).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 26 Jun 2025, 17:19.

Change

Previous filing in this sequence was filed on 08 Aug 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002031699 Primary reporting owner

Mack John Prosper

Relationship: Director
Address: C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE
Signature: /s/ Andrew Taylor, Attorney-in-Fact
Signature date: 26 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OBIO transaction

Common Stock, par value $0.0001 per share ("Common Stock")

Award

Transaction value: $0
Shares: +12,422
Change %: +97%
Price: $0.000000
Shares after: 25,286
Date: 24 Jun 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OBIO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +36,797
Change %
Price: $0.000000
Shares after: 36,797
Date: 24 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 36,797
Exercise price: $3.22
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on June 24, 2025 (the "Grant Date"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest in one installment on the earlier of (x) the one year anniversary of the Grant Date or (y) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such dates.

Footnote F2

The stock options will vest in one installment on the earlier of (x) the one year anniversary of the Grant Date or (y) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such dates.